MYC and glioblastoma: Xanthohumol is thought to destabilize c-Myc and promotes its ubiquitination as a consequence, resulting in the suppression of Akt/ flycogen synthase kinase-3 beta (GSK3β) axis and inhibition of glioblastoma cell proliferation.